AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
IDEXX Laboratories Q2 2025 Earnings Preview: EPS and Revenue Estimates
ByAinvest
Friday, Aug 1, 2025 12:42 pm ET1min read
IDEXX Laboratories is set to announce Q2 2025 earnings on August 4th. The consensus EPS estimate is $3.30 (+9.3% Y/Y) and the consensus revenue estimate is $1.07B (+6.6% Y/Y). Over the last 2 years, IDXX has consistently beaten EPS estimates by an average of 6.4%.
IDEXX Laboratories (NASDAQ: IDXX) is scheduled to release its second-quarter 2025 earnings results on Monday, August 4th, before the market opens. The consensus estimate for earnings per share (EPS) is $3.30, representing a 9.3% year-over-year (Y/Y) increase, while the consensus revenue estimate stands at $1.07 billion, indicating a 6.6% Y/Y growth. Over the last two years, IDEXX has consistently outperformed EPS estimates by an average of 6.4% [1].The company's strong performance is driven by several factors. The Companion Animal Group (CAG) is expected to have benefited from global net price improvement and higher volumes, with IDEXX VetLab consumables revenue growth likely driven by higher price realization and volume increases. International CAG Diagnostic recurring revenues are also anticipated to have benefited from new business gains, contributing to the robust expansion of IDEXX's premium instrument installed base. The Water and Livestock, Poultry, and Dairy (LPD) segments are also expected to have delivered solid revenues, with the Water segment benefiting from realized price increases and higher volumes, and the LPD division maintaining U.S. momentum [2].
IDEXX Laboratories' innovations, such as the IDEXX Cancer Dx diagnostic panel for canine lymphoma and the CatalystSmartQC Control, have gained commercial traction and are expected to have positively impacted the company's second-quarter revenues. The company's Zacks Rank of #3 and Earnings ESP of +0.34% suggest a higher likelihood of beating estimates [2].
Investors and financial professionals should closely monitor IDEXX Laboratories' earnings announcement for further insights into the company's performance and future prospects.
References:
[1] https://seekingalpha.com/news/4476706-idexx-laboratories-q2-2025-earnings-preview
[2] https://finance.yahoo.com/news/idexx-release-q2-earnings-whats-115600147.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet